81 results
Page 3 of 5
6-K
EX-99.1
1laol4fxw9
2 Jun 22
Legend Biotech Corp. 6-K
3:24pm
6-K
EX-99.1
qrpufbd
1 Jun 22
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
bgu72vme hpwo0ug3vd5
26 May 22
Legend Biotech Corp. 6-K
6:02am
6-K
EX-99.1
hc4m ktcl
18 May 22
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
n160z
9 May 22
Legend Biotech Corporation 6-K
6:32am
6-K
EX-99.1
dthh s8yl2k
6 May 22
Legend Biotech Corporation 6-K
4:02pm
6-K
EX-99.1
wmwwikbdkn7cvo
21 Apr 22
Legend Biotech Corporation 6-K
8:33am
6-K
EX-99.1
8p7scyeu ox6r35z6x
1 Apr 22
Legend Biotech Corp. 6-K
4:01pm
6-K
EX-99.1
u6efkum9jrbokx7k
25 Mar 22
Ciltacabtagene autoleucel, if approved by the European Commission (EC), will be Legend Biotech’s first EC-approved product
8:14am
6-K
EX-99.1
0y75q 817rq
18 Mar 22
Legend Biotech Corporation 6-K
4:10pm
6-K
EX-99.1
fx0zyle30bcgjvbgmxl
1 Mar 22
Legend Biotech Corp. 6-K
6:00am
6-K
EX-99.1
kegfc4h y5
18 Feb 22
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
usq33hc8ny3s yrc
15 Feb 22
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
tqkxz
11 Feb 22
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
5nkxr6ot
4 Jan 22
Legend Biotech Corporation Form 6-K
8:30am
6-K
EX-99.1
xpv5zaw6q8vl hizz
30 Dec 21
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
74538ygrute nxy
17 Dec 21
Announces Pricing of Public Offering
4:19pm
424B5
nwowkkh486u
17 Dec 21
Prospectus supplement for primary offering
4:16pm
424B5
0jffwc xy1
14 Dec 21
Prospectus supplement for primary offering
4:40pm